Scott B. Capps, VP, Clinical Research at CRYOLIFE INC (CRY), sold 16,594 shares at $10.30 ($171K) on 2016-02-19, disclosed to the SEC on 2016-02-23.
Seasonal sale ($171k) by VP, Clinical Research — this insider has traded CRY in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.24 | 1,594 | $16K | 9.6% |
| 2 | $10.30 | 418 | $4K | 2.5% |
| 3 | $10.30 | 14,582 | $150K | 87.9% |
| Total | $10.29 avg | 16,594 | $171K | 100% |
| Filing → |
| CRY | SELL | 2019-06-03 | $57K | — | Filing → |
| CRY | SELL | 2018-09-04 | $432K | — | Filing → |
| CRY | SELL | 2017-02-24 | $364K | — | Filing → |